Invention Grant
US08772044B2 Method of negative-ion MALDI analysis of neutral labeled sugars and screening disease markers
有权
中性标记糖的负离子MALDI分析方法和筛选疾病标记物
- Patent Title: Method of negative-ion MALDI analysis of neutral labeled sugars and screening disease markers
- Patent Title (中): 中性标记糖的负离子MALDI分析方法和筛选疾病标记物
-
Application No.: US11887365Application Date: 2006-03-27
-
Publication No.: US08772044B2Publication Date: 2014-07-08
- Inventor: Junko Amano , Koichi Tanaka
- Applicant: Junko Amano , Koichi Tanaka
- Applicant Address: JP Tokyo JP Kyoto
- Assignee: The Noguchi Institute,Shimadzu Corporation
- Current Assignee: The Noguchi Institute,Shimadzu Corporation
- Current Assignee Address: JP Tokyo JP Kyoto
- Agency: Cheng Law Group, PLLC
- Priority: JP2005-101536 20050331; JP2005-101537 20050331
- International Application: PCT/JP2006/306981 WO 20060327
- International Announcement: WO2006/106997 WO 20061012
- Main IPC: G01N33/00
- IPC: G01N33/00

Abstract:
The present invention provides a method for obtaining structural information conveniently and rapidly by generating a negative ion without adding an acidic substance to matrix, thereby improving sensitivity of measurement by a mass spectrometer, and by generating structural specific ions with high reproducibility, and a method for screening disease marker and a method for analyzing a sample containing a biomolecule. A method for mass spectrometry of a sugar chain comprising the steps of: preparing a sample containing a sugar chain; labeling the sugar chain with a labeling compound, to obtain a labeled sugar chain; and subjecting the labeled sugar chain to measurement of negative ions by using a MALDI mass spectrometer, thereby conducting analysis of the sugar chain. A method for screening disease marker comprising the steps of: (1) labeling the biomolecule X derived from a subject affected by a particular disease; subjecting the labeled biomolecule X′ to measurement of negative ions by a MALDI mass spectrometer, (2) separately, labeling the biomolecule Y derived from a subject unaffected by the particular disease; subjecting the labeled biomolecule Y′ to measurement of negative ions by a MALDI mass spectrometer; and (3) comparing mass spectrum of the labeled biomolecule X′ obtained in (1) with mass spectrum of the labeled biomolecule Y′ obtained in (2) to find mass spectrum peaks which are mutually different, thereby ascertaining presence of structure involved in expression of the particular disease.
Public/Granted literature
- US20090250604A1 Analysis Method for Biological Sample and Screening Method for Disease Marker Public/Granted day:2009-10-08
Information query